Frontlight ResearchEarly access
Trial site
Galo Saude Parcerias Cascais S.A.
- 9running trials
- 2closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Heart failure2 trials
- Obesity2 trials
- Aortic stenosis1 trial
- Chronic kidney disease1 trial
- Prostate cancer1 trial
- Triple-negative breast cancer1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 310 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Recruiting6 trials
- Active, not recruiting3 trials
- Completed2 trials
- Suspended1 trial
- Lead sponsor
- AstraZeneca2 trials
- Merck Sharp & Dohme LLC2 trials
- Novo Nordisk A/S2 trials
- Boehringer Ingelheim1 trial
- Glaxosmithkline Research & Development Limited1 trial
- and 4 more
Running trials
Active, not recruiting
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Aortic stenosis1 recruiting
- Heart failure1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026